Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Data availability

All data generated or analyzed during this study are included in this published article [and its Supplementary Information files].

References

  1. Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y, et al. Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant. 2006;38:377–84.

    Article  CAS  Google Scholar 

  2. Ramírez P, Brunstein CG, Miller B, Defor T, Weisdorf D. Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival. Bone Marrow Transplant. 2011;46:981–6.

    Article  Google Scholar 

  3. Akahoshi Y, Kimura S, Gomyo A, Hayakawa J, Tamaki M, Harada N, et al. Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome. Hematol Oncol. 2018;36:276–84.

    Article  CAS  Google Scholar 

  4. Mavroudis D, Read E, Cottler-Fox M, Couriel D, Molldrem J, Carter C, et al. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood. 1996;88:3223–9.

    Article  CAS  Google Scholar 

  5. Bittencourt H, Rocha V, Chevret S, Socie G, Esperou H, Devergie A, et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;99:2726–33.

    Article  CAS  Google Scholar 

  6. Ringdén O, Barrett AJ, Zhang MJ, Loberiza FR, Bolwell BJ, Cairo MS, et al. Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses. Br J Haematol. 2003;121:874–5.

    Article  Google Scholar 

  7. Gorin NC, Labopin M, Rocha V, Arcese W, Beksac M, Gluckman E, et al. Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow. Blood. 2003;102:3043–51.

    Article  CAS  Google Scholar 

  8. Rocha V, Labopin M, Gluckman E, Powles R, Arcese W, Bacigalupo A, et al. Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey. J Clin Oncol. 2002;20:4324–30.

    Article  Google Scholar 

  9. Pichler H, Witt V, Winter E, Boztug H, Glogova E, Pötschger U, et al. No impact of total or myeloid Cd34+ cell numbers on neutrophil engraftment and transplantation-related mortality after allogeneic pediatric bone marrow transplantation. Biol Blood Marrow Transpl. 2014;20:676–83.

    Article  CAS  Google Scholar 

  10. Remberger M, Törlén J, Ringdén O, Engstroöm M, Watz E, Uhlin M, et al. Effect of Total Nucleated and CD34(+) cell dose on outcome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:889–93.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Lina Alloush and Carlton Hughes from the human applications laboratory at St. Jude for assistance in collecting data.

Funding

This work was supported by NCI Cancer Center CORE Support Grant P30 CA 21765 and by ALSAC. JRW was supported by NCI Grant R25C0A23944.

Author information

Authors and Affiliations

Authors

Contributions

AS designed the study and wrote the manuscript. JRW and AYS collected the data and revised the manuscript. GK and YL performed the statistical analysis and revised the manuscript. SA and BT revised the manuscript and contributed to cell processing (SA) and patient management (BT).

Corresponding author

Correspondence to Ashok Srinivasan.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wells, J.R., Kang, G., Suliman, A.Y. et al. Delayed platelet recovery and mortality after allogeneic stem cell transplantation in children. Bone Marrow Transplant 57, 1347–1349 (2022). https://doi.org/10.1038/s41409-022-01726-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-022-01726-2

Search

Quick links